The Bridge to Transplant
It is estimated that there are nearly 50,000 people around the world that are in need of heart transplants. The average wait time for a donor heart is four to six months. For a patient with end-stage heart failure, a ventricular assist device or total artificial heart may be viable options to serve as a bridge to heart transplantation (Trivedi, 2014).
The symptoms of heart failure can be treated in several ways depending on the severity of illness. In early stages, non-invasive strategies such as life style changes, including diet and exercise, are usually recommended (Dumitru, 2015). These non-pharmacologic therapies include dietary sodium and fluid restriction, physical activity as appropriate, and attention
…show more content…
So, it will alternately send blood to the lungs and then to the body, instead of both at the same time as a natural heart does. The AbioCor is able to pump more than 10 liters per minute, which is enough for everyday activities.
Main Types of Total Artificial Hearts
Indications TAH
Compared with LVADs, the TAH has several potential advantages, including the ability to assist patients with severe biventricular failure; a lack of device pocket and thus a lessened risk of infection; and the opportunity to treat patients with systemic diseases (eg, amyloidosis, malignancy) who are not otherwise candidates for transplantation. (http://emedicine.medscape.com/article/163062-treatment#d22 )
You might need a TAH for one of two reasons: To keep you alive while you wait for a heart transplant; If you 're not eligible for a heart transplant, but you have end-stage heart failure in both ventricles. (https://www.nhlbi.nih.gov/health/health-topics/topics/tah)
Total Artificial Heart Implantation: Clinical Indications, Expected Postoperative Imaging Findings, and Recognition of Complications.
Transcatheter aortic valve replacement or TAVR is the latest technology used principally for the treatment of aortic stenosis, a condition in which one of the major valves of the heart, the aortic valve, becomes tight and stiff, usually as a result of aging (3). Since many patients who need aortic valve replacement for aortic stenosis are too sick to undergo major valve replacement surgery, they are unable to get the treatment they need. With the transcatheter aortic valve, this issue is bypassed because this valve can be implanted in the heart by accessing the patient’s heart through an artery in the groin. The valve can be inserted through a wire that can be pushed to the heart, and the old valve is simply pushed to the side when the new valve is implanted. This technology has been in use in the US with Edwards’ Sapiens valve since 2011 and has saved the lives of many patients with aortic stenosis (4).
The Burden of the disease is high with a prevalence of 3.4% 2. With the progressive nature of the disease and the increased severity of the symptoms made the surgery the gold standard for symptomatic AS patients ,however up to 30% of cases are considered too high risk for classical valve replacement surgery and remain untreated and experiencing poor prognosis . Fortunately , with the introduction of TAVR its offer a valuable option for the inoperable or at high risk of surgery patients3..the annual eligible candidate for this procedure expected to be 27,000 in 19 European countries and North America according to recent meta-analysis an...
They have now invented a “beating heart transplant.” It consists of a mechanical system to keep the heart beating, while it is being transferred to the candidate. Statistics have proven that these candidates have a higher recovery rate, because of the “beating heart.” Throughout reading above, it is a given that organ donation is vital to saving lives, but it is not deemed proper to be made mandatory.
As of February 2000 there were in the United States 67,340 people waiting for organ transplants.8 In 1998, 4,855 Americans on that list died waiting.8 Against this backdrop of critical need, physicians in Wisconsin are using a controversial drug, Regitine, to preserve organs from patients on life support who still have brain activity, but who are not expected to survive their injury or illness.4 These donors, who typically die of cardiac arrest following the removal of life-sustaining technologies, are called non-heart-beating donors (NHBDs) and differ from traditional "brain-dead" donors in that the cessation of heart beat is sufficient to declare death and begin organ removal.3
Congestive Heart Failure is when the heart's pumping power is weaker than normal. It does not mean the heart has stopped working. The blood moves through the heart and body at a slower rate, and pressure in the heart increases. This means; the heart cannot pump enough oxygen and nutrients to meet the body's needs. The chambers of the heart respond by stretching to hold more blood to pump through the body or by becoming more stiff and thickened. This only keeps the blood moving for a short while. The heart muscle walls weaken and are unable to pump as strongly. This makes the kidneys respond by causing the body to retain fluid and sodium. When the body builds up with fluids, it becomes congested. Many conditions can cause heart failure, and they are Coronary artery disease, Heart attack, Cardiomyopathy, and conditions that overwork the heart.
Currently, more than 118,617 men, women, and children are waiting for a transplant. With this high demand for organ transplants, there is a need for supply. According to the OPTN Annual report of 2008, the median national waiting time for a heart transplant is 113 days, 141 days for lungs, 361 days for livers, 1219 days for kidneys, 260 days for pancreas, 159 days for any part of the intestine. With this world of diseases and conditions, we are in desperate need of organs. Organ transplants, followed by blood into a donated organ transfusions, are ways medical procedures are helping better the lives of the patients.
Survival statistics after two tries really start to drop drastically (maybe 10% of people survive a year or more.) After the fourth transplant of a heart, kidney, or other organ, survival drops almost to zero" (How Many Hearts Should One Child Receive?). Even if there is a donor, the chances of surviving are low. Why would you waste a heart on yourself for the third or fourth time when you can give it to someone who hasn't even had their first heart transplant? According to Matthias Loebe, "In the first 4 months of 2011, 9,055 organ transplantations were performed in the United States.1 At that rate, more than 27,000 organs would be transplanted this year alone. However, this number still falls terribly short of the need for transplantable organs in the United States" (Multiple-Organ Transplantation from a Single Donor). The demand for organ transplantation has increased as it has become normal and effective to get a transplant. Getting a transplant will saves lives; however, supply and demand of organs is piling
When debating who will receive a heart transplant there is a list of criteria that must be met before the person becomes eligible to receive a transplant. The United Nation for Organ Transplant or UNO decides where each organ will go. UNO will first look at who is the sickest and without the heart transplant will pass away first. ( Trezpaz,DiMartni,2000). The patient that will receive the heart also has to be compatible with the person who had the heart. What this means is that they look at blood type, height, weight, among other medical factor to make sure that the person who receive the heart will not reject it( Uno,2015). Distance from the organ transplant center also plays a factor in who will receive the organ, Hearts can only be preserved
It is essential to the human body that the heart pump sufficient nutrient rich blood to the body’s cells, because the body won’t be able to function normally otherwise. When a heart muscle is unable to pump enough blood through to meet the body’s regular demand it is characterized as heart failure. Heart failure can usually be treated through conventional heart therapies and symptom management strategies, however conventional therapies don’t work for all patients with heart failure, this is what is depicted as advanced heart failure or end-stage heart failure. In other words “End stage” heart failure is when the condition becomes so severe that all conventional treatments no longer work, the only treatment that works for end stage heart failure is to have a heart transplantation-surgery to remove a person's diseased heart and replace it with a healthy heart from a deceased donor. However there are two large encompassing problems with this treatment. The first problem is that the patient is subject to shortages in donor organ availability and thus possible further decompensation and potential death while awaiting transplantation. According to the American Heart Association, there are over 500,000 new cases of end-stage heart failure in the United States every year. With only 2200 donor hearts available every year nearly 20-30% of the patients who die while they await a transplant. The second problem with this mode of treatment is that not all patients qualify for heart transplantation. Patients who have another disease in addition to end-stage heart failure do not qualify for heart transplantation. The discrepancy between the clinical need for donor hearts and the total number of hearts available, as well as the lack of treatment o...
Some advantages of the Total Artificial Heart include: 9.5 L/min of increased blood flow through both ventricles, faster bridge-to-transplant, and it eliminates complications caused by a diseased heart, such as kidney and liver failure. (“Syncardia”) “The first Total Artificial Heart implant was performed in Richmond, Va. on April 4, 2006 by a cardiac surgery team at VCU (Virginia Commonwealth University) in the Pauley Heart Center”(Lepley p.1). The major point to remember is that this is a mechanical heart that totally replaces a person’s own heart.
They found two out of five parallels per patient after the heart transplant. If you need a heart or lung transplant, the average waiting time is four months, however, a lung is eleven months, and the average wait time for a kidney is five years. (https://www.organdonor.gov) (https://www.quora.com) (http://www.medicaldaily.com) On top of organs being hard to get, they are also very hard to preserve.
One of the leading causes of death is congestive heart failure in which the ability of the heart to pump blood declines. This decline is caused by sudden damage to the heart as the result of heart attacks, deterioration of the heart from viral infections, malfunctioning of the valves or high blood pressure (Lange 13). The health of the heart also depends upon the functioning of the valves. The narrowing of valve openings decreases the pumping efficiency of the heart and limits the amount of blood that is pumped to the body. Valves may partially close reducing the amount of blood to the rest of the body and consequently putting excess pressure on the lungs (Lange 18). Five million Americans are currently living with heart failure and 50% of these patients will die within five years (Lange 13). The damage that leads to heart failure can only be cured through organ transplants, although medication and surgical options due serve to control symptoms. However, artificial hearts and pump-assisted devices may be potential alternatives to these methods.
If he is not a candidate for transplant, or while the patient is waiting for one, a Ventricular Assist Device (VAD) should be implanted. This works as a mechanical pump for the ventricles. He will need a BI- VAD for left and right heart failure. There will be two VAD devices placed bellow his heart, where tubes will be attached from these dives to his ventricles. The left VAD will have a tube on the left ventricle and another stemmed from VAD to Aorta. The pump will receive the blood from the left ventricle, and it will travel through the device and pump to the other tube attached to the Aorta and continue to the rest
Organ transplantation is, without a hesitation, one of the most major achievements in modern medicine. In many cases, it is the only effective therapy for end-stage organ failure and is broadly practiced around the world. According to the World Health Organization (WHO), around 21,000 liver transplants, 66,000 kidney transplants, and 6000 heart transplantation were performed globally in 2005.1 In addition, data showed that living kidney, liver, and lung donations declined, going from 7,004 in 2004 to 6,219 in 2008 making it a challenge for patients who are in need of organ transplant1. According to the WHO; an estimated 46,000 people in Egypt are in need of transplants, most of them liver and kidney transplants. Egypt’s population of around 80,471,879 is made up of the following ethnic group: Eastern stock (Egyptians, Bedouins, and Berbers) 99%, Greek, Nubian, Armenian other European 1%. Religious groups include: Muslim 94%, Coptic Christian and other 6%. Healthy life expectancy is estimated at 57.8 for males; and 60.2 for females and overall mortality rate per 1000 population of 240 males and 157 females. 2
The waiting list plays a key role if people get an organ transplant or not, more then 150,000 are waiting for solid organ transplants in the United States (Organ and Tissue Transplant). The waiting list is for critically ill patients with no alternative treatment besides getting a new organ. "On average 78 people in the United States get a transplant each day" (Transplant). Doctors only can put a patient on the waiting list or move a patient up or down the waiting list. The waiting list can not be influenced with money to help move the patient closer to the top of the waiting list. Without patients finding living organ donors or deceased organs donors, many will die waiting for a new organ that could eventually save their life.